"Haven't they been working with more than 1 partner?"
We do know that academic research partners with expertise in antisense oligonucleotides include the Murdoch University Centre for Comparative Genomics. I was thinking more along the lines of strategic commercial partnerships. What we do have now, however, is a partnership model. One would think that the 'Vision Pharma' model could be replicated e.g. de-Liver Pharma Pty Ltd.
Ann: Successful Major Milestone - Human Retina in a Dish Models, page-36
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.005(4.00%) |
Mkt cap ! $606.5M | |||
| Open | High | Low | Value | Volume |
| 12.5¢ | 13.0¢ | 12.0¢ | $415.6K | 3.255M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 112056 | 12.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.0¢ | 127118 | 2 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| PYC (ASX) Chart |